Thus, the mutants S707Y, S707F, and S707P, all occurring in CLL cells of ibrutinib-resistant patients, display higher basal PLC activity in intact cells than the mutants R665W and L845F. The gene discussed is HSPG2; the disease is B-cell chronic lymphocytic leukemia.